Literature DB >> 24831052

Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America.

R Abad1, E L López2, R Debbag3, J A Vázquez1.   

Abstract

Meningococcal serogroup W strains have been emerging throughout the current century with most of the isolates belonging to the sequence type (ST11)/electrophoretic type (ET37) clonal complex (ST11/E37 CC), particularly since the international outbreak following Hajj 2000. That outbreak appears to have triggered off that trend, contributing to the spread of W ST11/ET37 CC strains globally; however, local strains could be also responsible for increases in the percentage and/or incidence rates of this serogroup in some countries. More recently, unexpected increases in the percentage and incidence rate of W has been noticed in different countries located in the South Cone in Latin America, and W ST11/ET37 CC strains now appear as endemic in the region and an extensive immunization programme with tetravalent conjugate vaccine (covering serogroups A, C, Y and W) has been recently implemented in Chile. It is difficult to ascertain whether we are observing the emergence of W ST11 CC strains in different geographical areas or whether the Hajj 2000 strain is still spreading globally. Several aspects of the evolution of that situation are analysed in this paper, reviewing also the implications in immunization programmes. Closely related with the analysis of this potential evolution, it will be very interesting to monitor the evolution of serogroup W in the African meningitis belt after implementation of the extensive immunization programme with serogroup A conjugate vaccine that is currently underway. More data about carriers, transmission, clonal lineages, etc. are needed for taking decisions (target groups, outbreak control, defining the extent, etc.) to adapt the response strategy with potential interventions with broad coverage vaccines against the emergent serogroup W.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24831052      PMCID: PMC9151320          DOI: 10.1017/S0950268814001149

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  44 in total

1.  W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001.

Authors:  Susan J M Hahné; Steve J Gray; Natasha S Crowcroft; Tom Nichols; Edward B Kaczmarski; Mary E Ramsay
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

2.  Emergence and disappearance of W135 meningococcal disease.

Authors:  A Wilder-Smith; A Chow; K-T Goh
Journal:  Epidemiol Infect       Date:  2009-10-22       Impact factor: 2.451

3.  [Meningococcal disease: always present. Serogroup changes in the Southern Cone].

Authors:  Eduardo Luis López; Roberto Debbag
Journal:  Rev Chilena Infectol       Date:  2012-12       Impact factor: 0.520

4.  Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil.

Authors:  Ana Paula S Lemos; Lee H Harrison; Melina Lenser; Claudio T Sacchi
Journal:  J Infect       Date:  2010-01-06       Impact factor: 6.072

5.  Neisseria meningitidis serogroup W135 in Portugal: presence of the ST-11/ET-37 clonal complex.

Authors:  E Ferreira; R Dias; D Giorgini; M Caniça; M-K Taha
Journal:  Pathol Biol (Paris)       Date:  2008-01-07

6.  Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000.

Authors:  Muhamed-Kheir Taha; Dario Giorgini; Magaly Ducos-Galand; Jean-Michel Alonso
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 7.  The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape.

Authors:  M A P Sáfadi; S González-Ayala; A Jäkel; H Wieffer; C Moreno; A Vyse
Journal:  Epidemiol Infect       Date:  2012-08-09       Impact factor: 2.451

8.  Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.

Authors:  T Popovic; C T Sacchi; M W Reeves; A M Whitney; L W Mayer; C A Noble; G W Ajello; F Mostashari; N Bendana; J Lingappa; R Hajjeh; N E Rosenstein
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883

9.  Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts.

Authors:  Annelies Wilder-Smith; Timothy M S Barkham; Sindhu Ravindran; Arul Earnest; Nicholas I Paton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

10.  Travel-related Neisseria meningitidis serogroup W135 infection, France.

Authors:  Muhamed-Kheir Taha; Adèle Kacou-N'douba; Eva Hong; Ala Eddine Deghmane; Dario Giorgini; Sophia Lurette Okpo; Tatiana Kangah; Mireille Dosso
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

View more
  34 in total

1.  What Would be the Best Schedule for Prevention of Meningococcal Disease in All Ages? The UK Experience.

Authors:  H Findlow; R Borrow
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

2.  Development and Immunogenicity of a Brazilian Glycoconjugate vaccine against Meningococcal W in a Pilot Scale.

Authors:  Iaralice Medeiros de Souza; Milton Neto da Silva; Renata Chagas Bastos; Denise da Silva Gomes Pereira; Elza Cristina Schott Figueira; Ellen Jessouroun; Maria de Lourdes Moura Leal; Eliana Barreto-Bergter; Ivna Alana Freitas Brasileiro da Silveira
Journal:  Glycoconj J       Date:  2021-09-13       Impact factor: 2.916

3.  Genomic surveillance of Neisseria meningitidis serogroup W in Portugal from 2003 to 2019.

Authors:  Célia Bettencourt; Alexandra Nunes; João Paulo Gomes; Maria João Simões
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-11-17       Impact factor: 5.103

Review 4.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

5.  Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.

Authors:  Neil J Oldfield; Luke R Green; Julian Parkhill; Christopher D Bayliss; David P J Turner
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

6.  Population structure of invasive Neisseria meningitidis in the United States, 2011-15.

Authors:  Caelin C Potts; Sandeep J Joseph; How-Yi Chang; Alexander Chen; Jeni Vuong; Fang Hu; Laurel T Jenkins; Susanna Schmink; Amy Blain; Jessica R MacNeil; Lee H Harrison; Xin Wang
Journal:  J Infect       Date:  2018-06-30       Impact factor: 6.072

7.  A Survey of Serum Bactericidal Antibodies against Neisseria meningitidis Serogroups A, C, W and Y in Adolescents and Adults in the Republic of Korea.

Authors:  Jin-Han Kang; Yan Miao; SooYoung Lee; Jong-Hyun Kim; Kyung-Yil Lee; Sang Hyuk Ma; Dae Sun Jo; HyoYoung Song; Mendel Haag
Journal:  Infect Chemother       Date:  2016-03-31

8.  Meningococcal Disease in Korea: an Epidemiologic Study of the Underestimated Infectious Disease.

Authors:  Jung Yeon Heo
Journal:  Infect Chemother       Date:  2016-03-31

9.  Is the Emergence of the N. meningitidis Serogroup W ST-11 Hajj Outbreak Unraveling in the New Era of WGS?

Authors:  Bianca Törös; Susanne Jacobsson
Journal:  EBioMedicine       Date:  2015-10-09       Impact factor: 8.143

10.  Characterization of Carriage Isolates of Neisseria meningitides in the Adolescents and Young Adults Population of Bogota (Colombia).

Authors:  Jaime Moreno; Melissa Hidalgo; Carolina Duarte; Olga Sanabria; Jean Marc Gabastou; Ana Belén Ibarz-Pavon
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.